Depot-bromocriptine treatment for prolactinomas and acromegaly.

Depot-bromocriptine treatment for prolactinomas and acromegaly.

Fifteen patients with hyperprolactinaemia and pituitary macroadenomas (5 patients), microadenomas (6 patients), or acromegaly (4 patients) were given a single intramuscular injection of 50 mg bromocriptine bound to polylactic acid microspheres, depot-bromocriptine. None of the patients had any short...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Grossman, A, Ross, R, Wass, J, Besser, G
Format:	Journal article
Sprog:	English
Udgivet:	1986

Lignende værker

DEPOT BROMOCRIPTINE IN THE TREATMENT OF PROLACTINOMAS AND ACROMEGALY
af: Grossman, A, et al.
Udgivet: (1985)

The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.
af: Grossman, A, et al.
Udgivet: (1987)

Treatment of prolactinomas with megavoltage radiotherapy.
af: Grossman, A, et al.
Udgivet: (1984)

Prolactinomas.
af: Grossman, A, et al.
Udgivet: (1985)

Treatment of prolactinomas with megavoltage radiotherapy.
af: Grossman, A, et al.
Udgivet: (1984)

Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
af: Jenkins, P, et al.
Udgivet: (1996)

PROLACTINOMAS - REPLY
af: Grossman, A, et al.
Udgivet: (1985)

When to discontinue treatment of prolactinoma?
af: Wass, J
Udgivet: (2006)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
af: Jenkins, P, et al.
Udgivet: (2000)

New treatments for acromegaly.
af: Wass, J, et al.
Udgivet: (1998)

Massive prolactinoma with galactorrhoea in a prepubertal boy.
af: Ross, R, et al.
Udgivet: (1989)

Acromegaly: Treatment with somatostatin analogs
af: Karavitaki, N, et al.
Udgivet: (2005)

Evidence for the effectiveness of radiotherapy in the treatment of acromegaly.
af: Wass, J
Udgivet: (1997)

Acromegaly, colonic polyps and carcinoma.
af: Jenkins, P, et al.
Udgivet: (1997)

Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up.
af: Tsagarakis, S, et al.
Udgivet: (1991)

The pathology of median neuropathy in acromegaly.
af: Jenkins, P, et al.
Udgivet: (2000)

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
af: Herring, N, et al.
Udgivet: (2009)

Pegvisomant: a new treatment modality for acromegaly.
af: Karavitaki, N, et al.
Udgivet: (2004)

Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy.
af: Howlett, T, et al.
Udgivet: (1989)

The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
af: Karavitaki, N, et al.
Udgivet: (2005)

Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study.
af: Verhelst, J, et al.
Udgivet: (1991)

Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia.
af: Ciccarelli, E, et al.
Udgivet: (1989)

Uterine leiomyomata in women with acromegaly
af: Kaltsas, G, et al.
Udgivet: (2000)

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
af: Ismail, I.S., et al.
Udgivet: (1994)

Pituitary imaging using a labelled somatostatin analogue in acromegaly.
af: Ur, E, et al.
Udgivet: (1992)

Menstrual irregularity in women with acromegaly.
af: Kaltsas, G, et al.
Udgivet: (1999)

A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
af: Turner, H, et al.
Udgivet: (1999)

Diagnosis and management of prolactinomas and non-functioning pituitary adenomas.
af: Rogers, A, et al.
Udgivet: (2014)

Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
af: Sheaves, R, et al.
Udgivet: (1996)

Guidelines for acromegaly management.
af: Melmed, S, et al.
Udgivet: (2002)

Abnormal growth hormone release in response to human pancreatic growth hormone releasing factor in acromegaly.
af: Besser, G, et al.
Udgivet: (1983)

Long-term effects of radiotherapy for acromegaly.
af: Wass, J
Udgivet: (1996)

Radiotherapy in acromegaly: a protagonists viewpoint.
af: Wass, J
Udgivet: (2003)

Acromegaly: Beyond surgery.
af: Thanabalasingham, G, et al.
Udgivet: (2013)

Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine.
af: Ciccarelli, E, et al.
Udgivet: (1988)

A bromocriptine-responsive corticotroph adenoma secreting alpha-MSH in a patient with Cushing's disease.
af: Hale, A, et al.
Udgivet: (1988)

Investigation protocol: acromegaly and its investigation.
af: Duncan, E, et al.
Udgivet: (1999)

PROLACTINOMA IN A PREPUBERTAL CHILD - RESPONSE TO SURGERY, RADIOTHERAPY AND DOPAMINE AGONIST THERAPY
af: Sinn, D, et al.
Udgivet: (1985)

Bromocriptine for type 2 diabetes mellitus
af: Ooi, Cheow Peng, et al.
Udgivet: (2013)

Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
af: Wass, J
Udgivet: (2003)